Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GLP-1 receptor agonist medications (including semaglutide, dulaglutide, liraglutide, exenatide, and lixisenatide) are typically considered for type 2 diabetes when: Triple therapy with other diabetes medications is not effective, not tolerated, or contraindicated The person has a BMI 35 kg/m (adjusted by 2.5 kg/m for people from South Asian, Chinese, other Asian, Black African, or African-Caribbean backgrounds) and specific weight-related psychological or medical problems A lower BMI threshold may be appropriate if weight loss would benefit other obesity-related comorbidities Insulin would not be appropriate or acceptable to the person Treatment is usually continued only if there is a beneficial metabolic response (reduction in HbA1c and weight) after 6 months
Its important for patients to follow their healthcare providers dosing recommendations and discuss any persistent side effects, as there are often adjustments or supportive treatments that can help manage these symptoms
Kayser-Fleischer rings and sunflower cataract Your doctor will also check for Kayser-Fleischer (K-F) rings and sunflower cataract in the eyes
Simply book a consultation with our medical team
US$ 20.16
US$ 22.73
US$ 22.16
US$ 23.30
US$ 20.88
